HGF announces 2 new Partners

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

HGF Ltd is delighted to announce that from the 1st of May 2018, Kieran Killough and Dr Susan Keston have been promoted to Partner, increasing the Partner group to 53 Partners.
These promotions are part of the firm’s strategic growth plans. The firm continues its expansion into 2018 and has recently increased to 16 offices across Europe including the UK, Ireland, The Netherlands and Switzerland, with further plans to expand throughout the year.

Paul Sanderson, CEO commented, “It is my pleasure to announce that Kieran and Susan have joined the Partner group. They have continuously demonstrated HGF’s values and constantly impress their clients with their technical and legal expertise. These promotions recognise their hard work and dedication to the firm and their clients.”